Available company data, source links and archived checks for Applied Materials. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Quarter ended 2026-07-26 · consolidated · Company filing
| Quarter | Revenue / income | YoY | Profit | YoY | Net margin | Source |
|---|---|---|---|---|---|---|
| Jul 2026 | Revenue: $9.1 bn | +24.8% | Net profit: $2.5 bn | +42.7% | 27.8% | Company filing source |
| Apr 2026 | Revenue: $7.9 bn | +11.4% | Net profit: $2.8 bn | +31.3% | 35.5% | Company filing source |
| Jan 2026 | Revenue: $7.0 bn | -2.1% | Net profit: $2.0 bn | +71.0% | 28.9% | Company filing source |
| Oct 2025 | Revenue: $6.8 bn | -3.5% | Net profit: $1.9 bn | +9.6% | 27.9% | Company filing source |
| Jul 2025 | Revenue: $7.3 bn | +7.7% | Net profit: $1.8 bn | +4.3% | 24.4% | Company filing source |
| Apr 2025 | Revenue: $7.1 bn | +6.8% | Net profit: $2.1 bn | +24.1% | 30.1% | Company filing source |
YoY means change from the same quarter a year earlier. — means no comparable figure is available. Older entries with incomplete source details have not been revalidated under the current checks.
(In millions)
Column boundaries are incomplete. Use the source document to interpret these figures.
| | | | | | | | | | | | | | | | | | | Fiscal Year | 2025 | | 2024 | | 2023 | | | | | | | Cash flows from operating activities: | | | | | | Net income | $ | 6,998 | | | $ | 7,177 | | | $ | 6,856 | | Adjustments required to reconcile net income to cash provided by operating activities: | | | | | | Depreciation and amortization | 435 | | | 392 | | | 515 | | Restructuring charges | 179 | | | — | | | — | | Deferred income taxes | 639 | | | (633) | | | 24 | | (Gain) loss and impairments on investments, net | (792) | | | (15) | | | (16) | | Share-based compensation | 668 | | | 577 | | | 490 |
(In millions)
Column boundaries are incomplete. Use the source document to interpret these figures.
| | | | | | | | | | | | | | | | | | | Fiscal Year | 2025 | | 2024 | | 2023 | | | | | | | Cash flows from operating activities: | | | | | | Net income | $ | 6,998 | | | $ | 7,177 | | | $ | 6,856 | | Adjustments required to reconcile net income to cash provided by operating activities: | | | | | | Depreciation and amortization | 435 | | | 392 | | | 515 | | Restructuring charges | 179 | | | — | | | — | | Deferred income taxes | 639 | | | (633) | | | 24 | | (Gain) loss and impairments on investments, net | (792) | | | (15) | | | (16) | | Share-based compensation | 668 | | | 577 | | | 490 | | Other | 31 | | | 62 | | | 56 | | Changes in operating assets and liabilities, net of amounts acquired: | | | | | | Accounts receivable | 49 | | | (69) | | | 903 | | Inventories | (494) | | | 304 | | | 207 | | Other current and non-current assets | (119) | | | 287 | | | (48) | | Accounts payable and accrued expenses | 307 | | | 281 | | | (138) | | Contract liabilities | (283) | | | (126) | | | (167) | | Income taxes payable | 250 | | | 389 | | | (20) | | Other liabilities | 90 | | | 51 | | | 38 | | Cash provided by operating activities | 7,958 | | | 8,677 | | | 8,700 | | Cash flows from investing activities: | | | | | | Capital expenditures | (2,260) | | | (1,190) | | | (1,106) | | Cash paid for acquisitions, net of cash acquired | (29) | | | — | | | (25) | | Proceeds from asset sale | 33 | | | — | | | — | | Proceeds from sales and maturities of investments | 5,528 | | | 2,451 | | | 1,268 | | Purchases of investments | (6,054) | | | (3,588) | | | (1,672) | | Cash used in investing activities | (2,782) | | | (2,327) | | | (1,535) |
(In millions)
Column boundaries are incomplete. Use the source document to interpret these figures.
| | | | | | | | | | | | | | | | | | | Fiscal Year | 2025 | | 2024 | | 2023 | | | | | | | Cash flows from operating activities: | | | | | | Net income | $ | 6,998 | | | $ | 7,177 | | | $ | 6,856 | | Adjustments required to reconcile net income to cash provided by operating activities: | | | | | | Depreciation and amortization | 435 | | | 392 | | | 515 | | Restructuring charges | 179 | | | — | | | — | | Deferred income taxes | 639 | | | (633) | | | 24 | | (Gain) loss and impairments on investments, net | (792) | | | (15) | | | (16) | | Share-based compensation | 668 | | | 577 | | | 490 | | Other | 31 | | | 62 | | | 56 | | Changes in operating assets and liabilities, net of amounts acquired: | | | | | | Accounts receivable | 49 | | | (69) | | | 903 | | Inventories | (494) | | | 304 | | | 207 | | Other current and non-current assets | (119) | | | 287 | | | (48) | | Accounts payable and accrued expenses | 307 | | | 281 | | | (138) | | Contract liabilities | (283) | | | (126) | | | (167) | | Income taxes payable | 250 | | | 389 | | | (20) | | Other liabilities | 90 | | | 51 | | | 38 | | Cash provided by operating activities | 7,958 | | | 8,677 | | | 8,700 | | Cash flows from investing activities: | | | | | | Capital expenditures | (2,260) | | | (1,190) | | | (1,106) | | Cash paid for acquisitions, net of cash acquired | (29) | | | — | | | (25) | | Proceeds from asset sale | 33 | | | — | | | — | | Proceeds from sales and maturities of investments | 5,528 | | | 2,451 | | | 1,268 | | Purchases of investments | (6,054) | | | (3,588) | | | (1,672) | | Cash used in investing activities | (2,782) | | | (2,327) | | | (1,535) | | Cash flows from financing activities: | | | | | | Debt borrowings, net of issuance costs | 991 | | | 694 | | | — | | Debt repayments | (700) | | | — | | | — | | Proceeds from commercial paper | 503 | | | 401 | | | 991 | | Repayments of commercial paper | (502) | | | (400) | | | (900) | | Proceeds from common stock issuances | 261 | | | 243 | | | 227 | | Common stock repurchases | (4,895) | | | (3,823) | | | (2,189) | | Tax withholding payments for vested equity awards | (248) | | | (291) | | | (179) | | Payments of dividends to stockholders | (1,384) | | | (1,192) | | | (975) | | Payments of debt issuance costs | (3) | | | — | | | — | | Repayments of principals on finance leases | — | | | (102) | | | (7) | | Cash used in financing activities | (5,977) | | | (4,470) | | | (3,032) |
(In millions)
Column boundaries are incomplete. Use the source document to interpret these figures.
| | | | | | | | | | | | | | | | | | | Fiscal Year | 2025 | | 2024 | | 2023 | | | | | | | Cash flows from operating activities: | | | | | | Net income | $ | 6,998 | | | $ | 7,177 | | | $ | 6,856 | | Adjustments required to reconcile net income to cash provided by operating activities: | | | | | | Depreciation and amortization | 435 | | | 392 | | | 515 | | Restructuring charges | 179 | | | — | | | — | | Deferred income taxes | 639 | | | (633) | | | 24 | | (Gain) loss and impairments on investments, net | (792) | | | (15) | | | (16) | | Share-based compensation | 668 | | | 577 | | | 490 | | Other | 31 | | | 62 | | | 56 | | Changes in operating assets and liabilities, net of amounts acquired: | | | | | | Accounts receivable | 49 | | | (69) | | | 903 | | Inventories | (494) | | | 304 | | | 207 | | Other current and non-current assets | (119) | | | 287 | | | (48) | | Accounts payable and accrued expenses | 307 | | | 281 | | | (138) | | Contract liabilities | (283) | | | (126) | | | (167) | | Income taxes payable | 250 | | | 389 | | | (20) | | Other liabilities | 90 | | | 51 | | | 38 | | Cash provided by operating activities | 7,958 | | | 8,677 | | | 8,700 | | Cash flows from investing activities: | | | | | | Capital expenditures | (2,260) | | | (1,190) | | | (1,106) | | Cash paid for acquisitions, net of cash acquired | (29) | | | — | | | (25) | | Proceeds from asset sale | 33 | | | — | | | — | | Proceeds from sales and maturities of investments | 5,528 | | | 2,451 | | | 1,268 | | Purchases of investments | (6,054) | | | (3,588) | | | (1,672) | | Cash used in investing activities | (2,782) | | | (2,327) | | | (1,535) | | Cash flows from financing activities: | | | | | | Debt borrowings, net of issuance costs | 991 | | | 694 | | | — | | Debt repayments | (700) | | | — | | | — | | Proceeds from commercial paper | 503 | | | 401 | | | 991 | | Repayments of commercial paper | (502) | | | (400) | | | (900) | | Proceeds from common stock issuances | 261 | | | 243 | | | 227 | | Common stock repurchases | (4,895) | | | (3,823) | | | (2,189) | | Tax withholding payments for vested equity awards | (248) | | | (291) | | | (179) | | Payments of dividends to stockholders | (1,384) | | | (1,192) | | | (975) | | Payments of debt issuance costs | (3) | | | — | | | — | | Repayments of principals on finance leases | — | | | (102) | | | (7) | | Cash used in financing activities | (5,977) | | | (4,470) | | | (3,032) | | Increase (decrease) in cash, cash equivalents and restricted cash equivalents | (801) | | | 1,880 | | | 4,133 | | Cash, cash equivalents and restricted cash equivalents — beginning of period | 8,113 | | | 6,233 | | | 2,100 | | Cash, cash equivalents and restricted cash equivalents — end of period | $ | 7,312 | | | $ | 8,113 | | | $ | 6,233 | | Reconciliation of cash, cash equivalents, and restricted cash equivalents | | | | | | Cash and cash equivalents | $ | 7,241 | | | $ | 8,022 | | | $ | 6,132 | | Restricted cash equivalents included in deferred income taxes and other assets | 71 | | | 91 | | | 101 | | Total cash, cash equivalents, and restricted cash equivalents | $ | 7,312 | | | $ | 8,113 | | | $ | 6,233 |
(In millions)
Column boundaries are incomplete. Use the source document to interpret these figures.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fiscal Year | 2025 | | 2024 | | 2023 | Supplemental cash flow information: | | | | | | Cash payments for income taxes | $ | 1,504 | | | $ | 957 | | | $ | 1,006 | | Cash refunds from income taxes | $ | 90 | | | $ | 15 | | | $ | 53 | | Cash payments for interest | $ | 239 | | | $ | 205 | | | $ | 205 |
See accompanying Notes to Consolidated Financial Statements.
52
Keep its available filings, dated fact checks and disclosure alerts together. Your saved country sets your market and its research schedule.
Start free — first week on us →Company data and archived claim checks are shown with available sources. Check the source and date before relying on a figure. This is not investment advice or a recommendation. Investment in securities markets is subject to market risks. Research on this site is produced with substantial use of AI. Terms, disclosures and grievances